SCHEMBL4198638

SCHEMBL4198638

C=C(C)C(=O)OC(COc1ccc(-c2ccccc2)cc1)COc1cc(C)c(OCC(COc2ccc(-c3ccccc3)cc2)OC(=O)C(=C)C)c(C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.41
PPARG P37231 2/20 0.41
PPARA Q07869 2/20 0.41
PPARD Q03181 1/20 0.41
THRB P10828 1/20 0.39
LMNA P02545 1/20 0.38
PTGER4 P35408 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
GSTP1 P09211 1/20 0.37
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
HDAC3 O15379 3/20 0.36
HDAC4 P56524 3/20 0.36
HDAC1 Q13547 3/20 0.36
HDAC7 Q8WUI4 3/20 0.36
HDAC2 Q92769 3/20 0.36
HDAC10 Q969S8 3/20 0.36
HDAC11 Q96DB2 3/20 0.36
HDAC8 Q9BY41 3/20 0.36
HDAC6 Q9UBN7 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4197210 0.95 MAPT (0.41) MAPTPPARGPPARAPPARDTHRB
SCHEMBL4198613 0.90 THRB (0.43) MAPTPPARGPPARATHRBLMNA
SCHEMBL4197511 0.89 MAPT (0.50) MAPTLMNASMN1; SMN2NPC1RAB9A
SCHEMBL4188595 0.89 MAPT (0.50) MAPTLMNASMN1; SMN2NPC1RAB9A
SCHEMBL4194741 0.88 THRB (0.40) MAPTPPARGPPARATHRBSMN1; SMN2
SCHEMBL4202672 0.87 RXRA (0.42) PPARGPPARATHRBPTGER4
SCHEMBL4197201 0.87 MAPT (0.47) MAPTLMNASMN1; SMN2NPC1RAB9A
SCHEMBL4184734 0.86 MAPT (0.45) MAPTLMNA
SCHEMBL4197470 0.86 MAPT (0.39) MAPTPPARGPPARAPPARDTHRB
SCHEMBL4198139 0.85 RXRA (0.49) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1627867-B1 (METH)ACRYLIC ESTER COMPOUND AND USE THEREOF MITSUI CHEMICALS INC (JP) 2016-01-20 EP disclosed
US-7534909-B2 (Meth) acrylic ester compound and use thereof MITSUI CHEMICALS, INC. (JP) 2009-05-19 US disclosed
US-20070078198-A1 (Meth) acrylic ester compound and use thereof MITSUI CHEMICALS, INC. (JP) 2007-04-05 US disclosed
EP-1627867-A1 (METH)ACRYLIC ESTER COMPOUND AND USE THEREOF Mitsui Chemicals, Inc. (JP) 2006-02-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070078198-A1 (Meth) acrylic ester compound and use thereof METTL14, PAM, TAS2R41 MAPT 2073/4885PPARG 3465/4885PPARA 3322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.